Microneedles Drug Delivery Market Overview
The global microneedles drug delivery market size reached US$ 6.28 billion in 2025 and is expected to reach US$ 15.13 billion by 2032, growing with a CAGR of 8.20% during the forecast period 2026-2032.
Microneedle drug delivery is a device made by arranging hundreds of Microneedles in arrays on a tiny patch to deliver a sufficient amount of drug to give a required therapeutic response. This creates a direct transport pathway for a drug to travel into the viable epidermis avoiding contact with nerve fibers and blood vessels present in the dermal layers. The different types of materials are used in the manufacturing of microneedle depending upon their properties, such as ceramic, silicon, silica glass, carbohydrate, and polymers.
Microneedles Drug Delivery Market Dynamics
The microneedles drug delivery market growth is due to the availability of safer alternatives to conventional hypodermic injection. Furthermore, growing adoption in safety issues is also fueling the growth of microneedle drug delivery. As percenters for disease control and prevention, introducing a new microneedle patch could make it easier to vaccinate people in case of preventable diseases. Thus, vaccinations for various medical conditions such as measles boost the demand for the microneedle drug delivery market. Also, the Microneedle patch can be administered by minimally trained healthcare workers.
Increasing prevalence of diabetes is expected to drive the growth in the forecast period
The market is expected to surge in the coming years due to the increasing prevalence of diabetes globally. According to the International Diabetes Federation, around 463 million adults had been living with diabetes in 2019, and the number has been expected to rise to 700 million by 2045. Microneedles have proven to be an effective way to provide and deliver insulin based on glucose levels in a patient’s body. For instance, in March 2020, a research team, which a UCLA bioengineering professor led, had created a novel and coin sizes adhesive polymer patch using microneedles. This development is expected to have a positive impact on the market in the coming years.
Growing vaccinations for various medical conditions such as measles boost the demand for the microneedle drug delivery market
According to the Centers for Disease Control and Prevention, a new microneedle patch could make it easier to vaccinate people against measles and other vaccine-preventable diseases. Measles, a highly contagious virus, can affect the population in large numbers, for which precautions during vaccine preparation and vaccination should be taken care of. Around 20 million people are affected with measles every year, and unfortunately, global coverage with the measles vaccine has been stagnant for the last few years at around 85%, which is below the coverage percentage. Hence, microneedle patches are designed to administer by minimally trained workers and simplify the storage, distribution, and disposal process.
Microneedles have few concerns like drug degradation, poor absorption are likely to hinder the market growth.
Drug degradation, local irritation, poor absorption, and variability in absorption are expected to hinder the microneedle drug delivery market growth. Another challenge with dissolving microneedles is the incomplete penetration of these devices into the skin leading to drug wastage. Delivery of macromolecules with high hydrophilicity and molecular weight through microneedles is a challenge for delivery across the skin's surface.
Key Takeaways
- Microneedles offer minimally invasive drug delivery: Microneedle systems can bypass the skin barrier and support transdermal and intradermal delivery of peptides, proteins, vaccines and other active pharmaceutical ingredients.
- Dissolving microneedles remain a major research focus: Their ability to dissolve after application and avoid sharp waste makes them attractive for transdermal delivery, although improving drug loading and absorption remains a key research challenge.
- Biologics are an important application area: Research is examining microneedle delivery of insulin, GLP-1 receptor agonists, monoclonal antibodies and cancer vaccines, with studies exploring controlled and responsive release.
- Smart microneedle systems are gaining attention: Disease-specific designs, stimuli-responsive materials and programmable delivery approaches are being investigated to provide more targeted and controlled drug administration.
- Scalable manufacturing remains a key challenge: High-throughput manufacturing, consistent product quality, suitable applicators and clear regulatory pathways remain important for wider commercial adoption.
- Delivery performance depends on design and drug characteristics: Factors such as needle length, drug hydrophilicity and the sequence of drug application can affect microneedle-assisted drug delivery.
- Clinical translation is still developing: Despite extensive laboratory research, regulatory approval and commercialization of microneedle array patches remain challenging, particularly for drug-device combination products.
Microneedles Drug Delivery Segment Analysis
The hydrogel-forming microneedle segment is expected to hold largest share in this market segment
These are the new types of MNs with swellable material composition, absorbing and swell interstitial fluid to form a 3D network. This swelled network behaves as a hydrogel conduit for the delivery of drugs from the attached reservoir in a controlled manner. This type of MNs leaves no material residue upon removal. Larger doses can be administered at a controlled rate using hydrogel-forming needles. Different drugs from small hydrophilic molecules (theophylline) to high molecular weight molecules (insulin) have been reported to deliver through hydrogel-forming needles.
The cardiovascular segment is expected to hold largest share in this market segment
Cardiovascular is a highly growing application segment because of the increasing prevalence of cardiovascular diseases and stroke globally. According to WHO, 17.5 million people died from cardiovascular diseases in 2012, representing 31% of global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease, and 6.7 million were due to stroke. For instance, SeriTech microneedle patches show strong potential in healing heart attack victims by introducing a microneedle patch “integrated with cardiac stromal cells for therapeutic heart regeneration after acute myocardial infarction (MI).
The hospitals segment is expected to hold largest share in this market segment
The hospital segment is expected to dominate the microneedles drug delivery market by value due to the rise in chronic diseases like diabetes, migraine, cancer, measles in hospitals and the rise in the number of hospitals due to ongoing urbanization. Moreover, an increasing number of geriatric populations with health-related problems. According to the United Census Bureau, the global-female-geriatric population will reach 4,139 million by 2030 from 3,601 million in 2015. For instance, Nemaura Pharma has developed a Micro-Patch™ solid-dose teriparatide microneedle product, to prevent fractures in vulnerable elderly osteoporosis patients.
Microneedles Drug Delivery Geographical Analysis
North America region holds the largest market share of global microneedles drug delivery market
North America dominates the global microneedle drug delivery market due to high per capita healthcare expenditure in patient awareness. Early-phase diagnosis and treatment of disease and easy regulations for transdermal drug delivery vaccines drive the medical biotechnology market, which is expected to drive the microneedle drug delivery in North America. For instance, In June 2021, TSRL and PharmaTher announced that they had teamed up to develop microneedles patches. The novel partnership and collaboration would be used to collect and pool resources and intelligence to develop intradermal delivery devices for their use in therapeutic areas of field and focus. Both the companies had been involved in the development of the microneedle delivery system. PharmaTher had licensed microneedle technology from the University of California in the year 2020, and TSRL had been working on microneedle prototype patches, with support from the reputed National Institute of Allergy and Infectious Diseases.
Microneedles Drug Delivery Competitive Landscape
The global microneedles drug delivery market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass, Microdermics Inc, Zosano Pharma Corporation, Micropoint Technologies Pte Ltd, BuBclean, MyLife Technologies, Innoture Medical Technology Limited, Phillips Plastic Corporation, Corium International, Inc., Stemedica Cell Technologies, Inc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, Zosano Pharma has unveiled its Qtrypta zolmitriptan intracutaneous microneedle system, for migraine treatments, which is being reviewed for approval by the FDA.
Microneedles Drug Delivery Market Key Companies to Watch
3M
Overview: The 3M Company is an American multinational conglomerate corporation operating in worker safety, US health care, and consumer goods. 3M began in 1902, and the company produces over 60,000 products under several brands.
Product Portfolio: The Company’s portfolio comprised of include adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films.
Key Developments:
- September 2026 – Researchers published a study in Discover Nano reviewing next-generation microneedle patches for transdermal therapeutics and diagnostics, covering minimally invasive delivery, controlled drug release, therapeutic monitoring and point-of-care applications.
- September 2026 – A study published in the International Journal of Pharmaceutics introduced a cargo-aware design framework for dissolving microneedles, examining how microneedle geometry and mechanical properties influence delivery of small and large molecules, including GLP-1 receptor agonists.
- September 2026 – Researchers from Yonsei University and collaborators reported a hydrogel-forming microneedle platform for targeted posterior-eye drug delivery. The system was evaluated for delivery of TOP-V122 through the suprachoroidal space and demonstrated drug permeation and preliminary results in rabbits.
- July 2026 – An international research collaboration published a review in the Journal of Controlled Release covering microneedle array platforms for drug delivery and biomarker sensing. The study examined skin mechanics, microneedle design, scalable manufacturing and challenges associated with clinical translation.
- April 2026 – Researchers published a multicenter randomized pivotal trial evaluating biodegradable microneedle acupuncture for dry-eye treatment. The study involved researchers from Dongshin University and MEDICRO and was published in Integrative Medicine Research.
- April 2026 – Research published in Biosensors and Bioelectronics demonstrated a single-use microneedle biosensor for detecting clinically relevant glucose in interstitial fluid, supporting the development of minimally invasive microneedle-based monitoring technologies.
Why Purchase the Report?
- Visualize the composition of the microneedles drug delivery market segmentation by product type, application, end-user and region highlighting the key commercial assets and players.
- Identify commercial opportunities in microneedles drug delivery market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of microneedles drug delivery market - level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global microneedles drug delivery market report would provide an access to an approx. 40+ market data table, 45+ figures and 220 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
